Feasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) Intervention
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Eastern Cooperative Oncology Group
Gustave Roussy, Cancer Campus, Grand Paris
Kaiser Permanente
University of Pennsylvania
Duke University
Ulsan University Hospital
University of Colorado, Denver
Unity Health Toronto
Colorado State University
Universidad Complutense de Madrid
Dokuz Eylul University
University of Salamanca
AC Camargo Cancer Center
Vejle Hospital
City of Hope Medical Center
UNC Lineberger Comprehensive Cancer Center
Virginia Commonwealth University
University of Calgary
New Mexico Cancer Research Alliance
Arab American University (Palestine)
Centre Hospitalier de Valence
Centre for Research and Technology Hellas
Wake Forest University Health Sciences
University of Alabama at Birmingham
University of Arizona
Memorial Sloan Kettering Cancer Center
Institut du Cancer de Montpellier - Val d'Aurelle
Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León
Stanford University
Cyprus University of Technology
Stanford University
Universidade Federal de Pernambuco
Centre Hospitalier Henri Duffaut - Avignon
University of Colorado, Denver
Tel Aviv University
Changhai Hospital
Northwestern University
VA Office of Research and Development
Comenius University
Eastern Cooperative Oncology Group
University of Michigan Rogel Cancer Center
Blue Note Therapeutics
Charles Drew University of Medicine and Science
Roswell Park Cancer Institute
Milton S. Hershey Medical Center
IMU University, Malaysia
Institut BergoniƩ
Ohio State University Comprehensive Cancer Center
Albert Einstein College of Medicine